95044 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
LIGAND-ENABLED SCALABLE C-H HYDROXYLATION OF BENZOIC AND PHENYLACETIC ACIDS AT ROOM TEMPERATURE
#2CHROMEN-2-ONE MODULATORS OF POLRMT
#3TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#4FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM
#5CAGED GLUTAMATE UNLEASHED BY BLUE AND GREEN LIGHT: INNOVATIVE PHOTOSENSITIVE CONTROL
#62-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY] PROPANAMIDO DERIVATIVES
#7MEK IMMUNE ONCOLOGY INHIBITORS AND THERAPEUTIC USES THEREOF
#8PROCESS OF PREPARING HIV CAPSID INHIBITOR
#9COMPOUND HAVING PHOTOCLEAVABLE MOIETY, CONJUGATE, AND SCREENING METHOD USING SAME
#10SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
#11HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT
#12QUANTUM DOT LIGAND, PREPARATION METHOD FOR QUANTUM DOT FILM LAYER, AND QUANTUM DOT LIGHT EMITTING DEVICE
#13DYE-LABELED POLYMERS AND METHODS FOR PREPARING SAME
#14FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF
#15INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF
#16PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS
#17PSMA INHIBITOR, COMPOUND AND APPLICATION
#18RESIST COMPOSITION AND PATTERN FORMING PROCESS
#19SLC26A3 inhibitors and use thereof
#20PRODRUGS, ANALOGS OR DERIVATIVES OF ANTHOCYANIDIN AS ANTIVIRAL AGENTS
#21CHIRALITY SENSING WITH MOLECULAR CLICK CHEMISTRY PROBES
#22COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE WASTING AND OTHER CONDITIONS
#23PROCESS FOR PREPARING A COUMARIN-CAGED FORSKOLIN DERIVATIVE, FORSKOLIN DERIVATIVE AND USE OF SAID FORSKOLIN DERIVATIVE
#24Stabilization of amyloidogenic immunoglobulin light chains
#25Sulfonylureas and related compounds and use of same
#26TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#27SLC26A3 inhibitors and use thereof
#28Inhibitors of RSV replication and applications thereof
#29Detection method and detection probe for colibactin and colibactin-producing bacteria
#30TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#31Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
#32Thiol-based fluorescent probe for reactive species
#33Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof
#34Sulfonylureas and related compounds and use of same
#35METHODS AND COMPOSITIONS FOR EXPANSION OF HEMATOPOIETIC STEM AND/OR PROGENITOR CELLS EMPLOYING A CYTOCHROME P450 1B1 (CYP1B1) INHIBITOR OR A MUSASHI-2 (MSI2) ACTIVATOR
#36TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#37Transdermal formulations for delivery of capsaicinoids
#38Coumarin derivative as antiviral agent, pharmaceutical composition thereof, its preparation and use
#39Sulfonylureas and related compounds and use of same
#40Liquid-crystalline medium
#41Treatment or prophylaxis of proliferative conditions
#42Compounds for the treatment of mycobacterial infections
#43Liquid-crystalline medium
#44Liquid-crystalline medium
#45Liquid-crystalline medium
#46Inhibitors of the IRE-1/XBP-1 pathway and methods of using thereof
#47Labeling reagents and methods of their use
#48Methods for assaying alpha-L-iduronidase enzymatic activity
#49Photoresponsive coumarin based polymers: synthesis and applications
#50Coumarin compounds as receptor modulators with therapeutic utility
#51Enzyme assays on a droplet actuator
#52Compounds for treating spinal muscular atrophy
#53Novel Cyclic Phenoxy Compounds and Improved Treatments for Cardiac and Cardiovascular Disease
#54Composition for treating influenza A (HN) virus and a preparation method therefor
#55Compounds for the treatment of mycobacterial infections
#56Agents and methods for treating ischemic and other diseases
#57Assay for B-galactosidase activity
#58COMPOSITIONS AND METHODS TO TREAT DISEASE CHARACTERIZED BY CELLULAR PROLIFERATION AND ANGIOGENESIS
#59Site-specific labeling of affinity tags in fusion proteins
#60Composition for treating influenza a (HN) virus and a preparation method therefor
#61Coumarin-chalcones as anticancer agents
#62Fluorescence dye tagging scheme for mercury quantification and speciation
#63Method for assaying histone methylation enzyme activity
#64Coumarin compounds as receptor modulators with therapeutic utility
#65TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#66SITE-SPECIFIC LABELING OF AFFINITY TAGS IN FUSION PROTEINS
#67TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#68Method of hydrolyzing an enzymatic substrate
#69Compositions and methods for the detection of chemical warfare agents
#70Methods for assaying α-L-iduronidase enzymatic activity
#71Agents and methods for treating ischemic and other diseases
#72Composition for treating influenza A (HN) virus and a preparation method therefor
#73Photocleavable Linker Methods and Compositions
#74Coumarin derivative having antitumor activity
#75Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof
#76Treatment or prophylaxis of proliferative conditions
#77Fluorescent agent having ethynyl group
#78USE OF COUMARIN DERIVATIVES IN ANTIFUNGAL THERAPY
#79Methods for assaying alpha-L-iduronidase enzymatic activity
#80COUMARIN DERIVATIVES
#81Coumarin derivatives as ion channel openers
#82Photocleavable linker methods and compositions
#83Coumarin derivative having antitumor activity
#84SITE-SPECIFIC LABELING OF AFFINITY TAGS IN FUSION PROTEINS
#85Labeling reagents and methods of their use
#86SITE-SPECIFIC LABELING OF AFFINITY PEPTIDES IN FUSION PROTEINS
#87Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
#88Compounds, Compositions, and Methods
#89Difluorosubstituted heterocyclic compounds and the use thereof in the form of components in liquid crystalline media
#90Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
#91Use Of Trisubstituted Benzopyranones
#92Sulfonamide compound
#93Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
#94Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
#954-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewith
#96β-Benzyloxyaspartate derivatives with photosensitive groups
#97Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer
#98Therapeutic and prophylactic compositions and uses therefor
#99Coumarin derivatives as ion channel openers
#100Compounds and compositions for delivering active agents
#101Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
#102Novel 2H-chromene derivatives as selective estrogen receptor modulators
#103Site-specific labeling of affinity tags in fusion proteins
#104PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
#105Coumarin compounds and method for preparing and using the same
#106Lipid-rich plaque regressing agents
#107Compounds and compositions for delivering active agents
#108Chromene-containing compounds with anti-tubulin and vascular targeting activity
#109Site-specific labeling of affinity tags in fusion proteins
#11011β-hydroxysteroid dehydrogenase inhibitors
#111Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof
#112Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
#113Benzyl sulfonamide derivatives
#114Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
#115Coumarin derivatives for cancer therapy
#116Coumarin derivatives for cancer therapy